Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma.
Cancers
Cabibbo, Giuseppe G; Celsa, Ciro C; Enea, Marco M; Battaglia, Salvatore S; Rizzo, Giacomo Emanuele Maria GEM; Busacca, Anita A; Matranga, Domenica D; Attanasio, Massimo M; Reig, Maria M; Craxì, Antonio A; Cammà , Calogero C